ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Ganitumab Inhibits IGF-II-Dependent Ovarian Cancer Models (Clinical Cancer Research) Friday May 30th 2014


100) Cetuximab Resistance and HRAS Oncogenic Mutations in HNSCC (Clinical Cancer Research) Friday May 30th 2014


101) Zoledronic Acid in the Pre- and Postmenopausal Setting (Clinical Cancer Research) Friday May 30th 2014


102) Chimeric HER2 Vaccines Overcome Cancer Patient's T-cell Dysfunction (Clinical Cancer Research) Friday May 30th 2014


103) Driver Mutations in IDH1-Mutant Gliomas (Clinical Cancer Research) Friday May 30th 2014


104) IL-17A Modulates Change of CTCs and Affects Metastases (Clinical Cancer Research) Friday May 30th 2014


105) Cross-Species Oral Carcinoma Genomic Analysis (Clinical Cancer Research) Friday May 30th 2014


106) CD14+ and PD1+ Prognostic in Follicular Lymphoma (Clinical Cancer Research) Friday May 30th 2014


107) CADM1 versus CD7 Plot in HTLV-I Disease Progression (Clinical Cancer Research) Friday May 30th 2014


108) Variants of Prostate Cancer (Clinical Cancer Research) Friday May 30th 2014


109) ALK1 and VEGF Inhibition: A Promising New Combination (Clinical Cancer Research) Friday May 30th 2014


110) Platinum Drug Immunogenicity (Clinical Cancer Research) Friday May 30th 2014


111) Analysis Plans in Phase III Trials with Biomarkers (Clinical Cancer Research) Friday May 30th 2014


112) Postmenopausal Bone Loss as Fuel for Metastatic Cancer (Clinical Cancer Research) Friday May 30th 2014


113) P95 Cutoff Confirmation in Trastuzumab-Treated Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


114) Ficlatuzumab in Solid Tumor Patients with Liver Metastases (Clinical Cancer Research) Friday May 16th 2014


115) Bevacizumab PK/PD in Children (Clinical Cancer Research) Friday May 16th 2014


116) PD-L1 mRNA Positivity and Outcome in Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


117) Stromal-Response Signature in Cancer (Clinical Cancer Research) Friday May 16th 2014


118) Repeatability of FDG-PET/CT in Recurrent Ovarian Cancer (Clinical Cancer Research) Friday May 16th 2014


119) Inhibition of PDGFR{alpha} in Uterine Cancer (Clinical Cancer Research) Friday May 16th 2014


120) Temozolomide Prevention of Breast Cancer Brain Metastases (Clinical Cancer Research) Friday May 16th 2014


121) Metformin Sensitizes EGFR-TKI-Resistant Human Lung Cancer Cells (Clinical Cancer Research) Friday May 16th 2014


122) Determinants of Glioblastoma Response to ABT-888 (Clinical Cancer Research) Friday May 16th 2014


123) Anti-VEGF Antibodies Mitigate Radiation Necrosis in Brain (Clinical Cancer Research) Friday May 16th 2014


124) Targeting Cytomegalovirus Antigens for GBM Immunotherapy (Clinical Cancer Research) Friday May 16th 2014


125) JAK2 Inhibition in cHL and MLBCL (Clinical Cancer Research) Friday May 16th 2014


126) Celecoxib Sensitizes Lymphoma B Cells to Apoptosis (Clinical Cancer Research) Friday May 16th 2014


127) Id1-IGF-II-IGF-IR-AKT Signaling and Targeted Cancer Therapy (Clinical Cancer Research) Friday May 16th 2014


128) Detecting Plasma Tumor DNA in Early-Stage Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


129) MiR-200c Regulates CRC Stemness, Growth, Metastasis by Sox2 (Clinical Cancer Research) Friday May 16th 2014


130) miR-141 Inhibits Proliferation and Metastasis in RCC (Clinical Cancer Research) Friday May 16th 2014


131) Site-Specific Antigen Expression in Human Melanoma (Clinical Cancer Research) Friday May 16th 2014


132) FOXM1 Regulates the Warburg Effect (Clinical Cancer Research) Friday May 16th 2014


133) Pharmacodynamic Biomarkers (Clinical Cancer Research) Friday May 16th 2014


134) Implementing PD Assays in Multiple Laboratories (Clinical Cancer Research) Friday May 16th 2014


135) In Vivo Imaging of Drugs (Clinical Cancer Research) Friday May 16th 2014


136) Circulating Tumor Cells (Clinical Cancer Research) Friday May 16th 2014


137) GWAS in Cancer Pharmacogenomics (Clinical Cancer Research) Friday May 16th 2014


138) Germline PD PGx (Clinical Cancer Research) Friday May 16th 2014


139) PD Biomarkers in Cancer Medicine (Clinical Cancer Research) Friday May 16th 2014


140) The Language of Pharmacodynamics (Clinical Cancer Research) Friday May 16th 2014


141) Adaptive Response to Kinase Inhibition (Clinical Cancer Research) Friday May 16th 2014


142) Metformin in Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


143) Liquid Biopsies for Early Breast Cancers (Clinical Cancer Research) Friday May 16th 2014


144) Correction: hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications (Clinical Cancer Research) Thursday May 1st 2014


145) Correction: Genomic Estimates of Aneuploid Content in Glioblastoma Multiforme and Improved Classification (Clinical Cancer Research) Thursday May 1st 2014


146) Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient--Letter (Clinical Cancer Research) Thursday May 1st 2014


147) TGR Analysis in Phase I Clinical Trials--Response (Clinical Cancer Research) Thursday May 1st 2014


148) TGR Analysis in Phase I Clinical Trials--Letter (Clinical Cancer Research) Thursday May 1st 2014


149) Functional Gene Modules and Aromatase Inhibitor Response (Clinical Cancer Research) Thursday May 1st 2014


150) Personalized Cancer Treatment using Genomics and Avatar Models (Clinical Cancer Research) Thursday May 1st 2014


151) Associations between TRSN and SNPs (Clinical Cancer Research) Thursday May 1st 2014


152) MART-1 TCR Adoptive Cell Transfer (Clinical Cancer Research) Thursday May 1st 2014


153) Phase I Study of SAR245409 in Patients with Advanced Solid Tumors (Clinical Cancer Research) Thursday May 1st 2014


154) Phase I DC p53 Peptide Vaccine for Head and Neck Cancer (Clinical Cancer Research) Thursday May 1st 2014


155) CTLA4 Blockade Broadens the Peripheral TCR Repertoire (Clinical Cancer Research) Thursday May 1st 2014


156) MAPK Inhibition, Signaling, and Microenvironment in Hepatocellular Carcinoma (Clinical Cancer Research) Thursday May 1st 2014


157) mTOR Targeting and Autophagy in AML (Clinical Cancer Research) Thursday May 1st 2014


158) Pancreatic TICs in a Syngenic Murine Model (Clinical Cancer Research) Thursday May 1st 2014


159) BMP4-Secreted hAMSCs Repress Glioblastoma In Vivo (Clinical Cancer Research) Thursday May 1st 2014


160) Combination Strategies Targeting Sorafenib-Resistant AML (Clinical Cancer Research) Thursday May 1st 2014


161) Increased KIT Inhibition in GIST (Clinical Cancer Research) Thursday May 1st 2014


162) Prevalence and Clinical Implications of EBV+ DLBCL (Clinical Cancer Research) Thursday May 1st 2014


163) PI3K Pathway in DCIS (Clinical Cancer Research) Thursday May 1st 2014


164) The Role of miR-133b in Prostate Cancer (Clinical Cancer Research) Thursday May 1st 2014


165) Mutant PIK3CA in Head and Neck Cancer (Clinical Cancer Research) Thursday May 1st 2014


166) Vitamin D and Prostate Cancer (Clinical Cancer Research) Thursday May 1st 2014


167) Regulation of IL-32 in Gastric Cancer (Clinical Cancer Research) Thursday May 1st 2014


168) Tumor Heterogeneity and Targeted Therapies (Clinical Cancer Research) Thursday May 1st 2014


169) BRAF Attenuates Oxidative Phosphorylation (Clinical Cancer Research) Thursday May 1st 2014


170) Resistance to Kinase Inhibitors (Clinical Cancer Research) Thursday May 1st 2014


171) Epigenetic Therapy for Non-Small Cell Lung Cancer (Clinical Cancer Research) Thursday May 1st 2014


172) Vitamin D for Prostate Cancer Diagnosis and Treatment? (Clinical Cancer Research) Thursday May 1st 2014


173) Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer--Response (Clinical Cancer Research) Tuesday April 15th 2014


174) Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer--Letter (Clinical Cancer Research) Tuesday April 15th 2014


175) MK-2206 in AML (Clinical Cancer Research) Tuesday April 15th 2014


176) Ultra Low-Dose IL-2 Post Allogeneic HSCT (Clinical Cancer Research) Tuesday April 15th 2014


177) First-In-Human Phase I Study of Lurbinectedin (PM01183) (Clinical Cancer Research) Tuesday April 15th 2014


178) Phase I/II Study of Anti-IL-6 in Solid Tumors (Clinical Cancer Research) Tuesday April 15th 2014


179) [18F]-MFBG PET Imaging of Neuroblastoma (Clinical Cancer Research) Tuesday April 15th 2014


180) Prognostic Value of GABRE~miR-452~miR-224 Methylation in Prostate Cancer (Clinical Cancer Research) Tuesday April 15th 2014


181) Hypoxia-Driven Prognostic Gene Score in Colon Cancer (Clinical Cancer Research) Tuesday April 15th 2014


182) Tertiary Lymphoid Tissue in Colorectal Cancer (Clinical Cancer Research) Tuesday April 15th 2014


183) Metabolic Signature of Human Colorectal Cancer (Clinical Cancer Research) Tuesday April 15th 2014


184) PET Imaging of Caspase Activity In Vivo (Clinical Cancer Research) Tuesday April 15th 2014


185) RET Inhibition in Breast Cancer (Clinical Cancer Research) Tuesday April 15th 2014


186) Vintafolide Drug Combination Studies (Clinical Cancer Research) Tuesday April 15th 2014


187) Dual Inhibition of SET and Activated Kinases in Leukemia (Clinical Cancer Research) Tuesday April 15th 2014


188) High-Throughput Genomic Profiling of Archived Clinical Tumor Samples (Clinical Cancer Research) Tuesday April 15th 2014


189) Reasons for Phase III Failure in Hepatocellular Carcinoma (Clinical Cancer Research) Tuesday April 15th 2014


190) Molecular Biomarkers in Advanced RCC (Clinical Cancer Research) Tuesday April 15th 2014


191) Sensitivity and Resistance to JAK Inhibitors (Clinical Cancer Research) Tuesday April 15th 2014


192) Physiologic and Pathologic Effects of IL-15 (Clinical Cancer Research) Tuesday April 15th 2014


193) Dabrafenib and Trametinib (Clinical Cancer Research) Tuesday April 15th 2014


194) FDA Approval Summary: Crizotinib for ALK-Positive NSCLC (Clinical Cancer Research) Tuesday April 15th 2014


195) Antileukemic Activity of OP449 (Clinical Cancer Research) Tuesday April 15th 2014


196) Emerging Immunologic Biomarkers (Clinical Cancer Research) Tuesday April 15th 2014


View: prev | next

#RealTimeChem:

Announcements:


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()